Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers
Phase of Trial: Phase I/II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 04 Apr 2017 Status changed from not yet recruiting to recruiting.
- 16 Feb 2017 Planned initiation date changed from 1 Dec 2016 to 1 Feb 2017.
- 16 Dec 2016 New trial record